Cargando…
Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462]
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156986/ https://www.ncbi.nlm.nih.gov/pubmed/35644100 http://dx.doi.org/10.1016/j.esmoop.2022.100504 |
| _version_ | 1784718551048781824 |
|---|---|
| author | Castañeda, A. Gorostegui, M. Miralles, S.L. Chamizo, A. Patiño, S.C. Flores, M.A. Garraus, M. Lazaro, J.J. Santa-Maria, V. Varo, A. Muñoz, J.P. Mora, J. |
| author_facet | Castañeda, A. Gorostegui, M. Miralles, S.L. Chamizo, A. Patiño, S.C. Flores, M.A. Garraus, M. Lazaro, J.J. Santa-Maria, V. Varo, A. Muñoz, J.P. Mora, J. |
| author_sort | Castañeda, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9156986 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91569862022-06-02 Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] Castañeda, A. Gorostegui, M. Miralles, S.L. Chamizo, A. Patiño, S.C. Flores, M.A. Garraus, M. Lazaro, J.J. Santa-Maria, V. Varo, A. Muñoz, J.P. Mora, J. ESMO Open Corrigendum Elsevier 2022-05-26 /pmc/articles/PMC9156986/ /pubmed/35644100 http://dx.doi.org/10.1016/j.esmoop.2022.100504 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Castañeda, A. Gorostegui, M. Miralles, S.L. Chamizo, A. Patiño, S.C. Flores, M.A. Garraus, M. Lazaro, J.J. Santa-Maria, V. Varo, A. Muñoz, J.P. Mora, J. Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title | Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title_full | Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title_fullStr | Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title_full_unstemmed | Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title_short | Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462] |
| title_sort | corrigendum to “how we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the hospital sant joan de déu in barcelona, spain”: [esmo open, 7 (2022) 100462] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156986/ https://www.ncbi.nlm.nih.gov/pubmed/35644100 http://dx.doi.org/10.1016/j.esmoop.2022.100504 |
| work_keys_str_mv | AT castanedaa corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT gorosteguim corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT mirallessl corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT chamizoa corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT patinosc corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT floresma corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT garrausm corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT lazarojj corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT santamariav corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT varoa corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT munozjp corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 AT moraj corrigendumtohowweapproachthetreatmentofpatientswithhighriskneuroblastomawithnaxitamabexperiencefromthehospitalsantjoandedeuinbarcelonaspainesmoopen72022100462 |